PER
Click for more information
2.35% 8.7¢ percheron therapeutics limited

soon to report on phase iia ms trial

  1. poptop
    749 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    16/05/08
    00:52
    Post #: 3721358
    I'm surprised to see so little hotcopper activity on this one.

    ANP is one of the few uptrending biotechs on the ASX and it is now two months away from releasing phase IIa results on its multiple sclerosis therapy.

    It is always worth having a punt when trial results are imminent. Just make sure you close some of your positions prior to the announcement.
    ANP Price at posting: 0.0¢ Sentiment: ST Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.002(2.35%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.